Sign in
Taking people in United StatesNo phase

Disrupting Fear-based Memory Consolidation

Key facts

Who runs it
Emory University
Where
Atlanta, United StatesSee the 2 sites
Trial code
Status
Recruiting
People taking part
66 people, planned
Started
28 Nov 2022
Expected to end
Dec 2028
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Continuous theta burst stimulation (cTBS)
  • Sham continuous theta burst stimulation (cTBS)
Record updated
29 October 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Ability to provide informed consent
  • Willingness to participate in study
  • No history of musculoskeletal impairment or neurological disease
  • Clinical diagnosis of PTSD for individuals in the PTSD group

Who cannot take part

  • Current psychoactive medication usage
  • Participants that show signs of dementia (score < 20 on the Montreal Cognitive Assessment)
  • Participants that have a history of major head trauma, a neurodegenerative disorder, or recent (<6 months) substance abuse
  • Participants that had a recent history of Central Nervous System (CNS) active drugs that may influence cortical excitability or learning; or
  • Current symptoms of psychosis or bipolar disorder (as indicated by study staff through a clinical interview as part of that study)
  • Any participant outside the age range
  • Participants that report contraindications to TMS or MRI - if participating in the TMS/MRI experiments
  • The study will exclude adults unable to consent, individuals who are not yet adults, pregnant women and prisoners on scientific grounds and to minimize risk

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Post-traumatic stress disorder

This trial is currently available in United States.

  • Emory Rehabilitation HospitalAtlanta, United StatesContact: Michael Borich, PhDTaking people
  • Emory University HospitalAtlanta, United StatesContact: Michael Borich, PhDTaking people

About the trial

What the trial wants to find out

This project represents a unique collaborative opportunity to pursue the essential proof-of-principle demonstration that non-invasive interference of sensory cortical memory consolidation shortly after an emotional experience can attenuate the cued fear response and potentially reduce the risk of developing post-traumatic stress disorder (PTSD). If successful, the study results would anchor a potential advance in the treatment of patients after a traumatic event and seed future animal and clinical studies of emotional sensory cortical memory consolidation to reduce the prevalence and negative sequelae of PTSD.

The 2 groups in the trial

  • cTBS: Inhibitory Transcranial magnetic stimulation (TMS) to sensory CortexTreatment being tested

    Participants will undergo a Functional magnetic resonance imaging (fMRI) scan while performing a fear conditioning/extinction task at the Center for Systems Imaging- Emory University Hospital (CSI-EUH) and then either stay at CSI-EUH or relocate to the Neural Plasticity Research Laboratory at Emory Rehabilitation Hospital. Participants will then be randomly assigned to either receive active or sham continuous theta burst stimulation (cTBS) to transiently disrupt neural activity in the targeted sensory cortex region specifically during the sensory memory consolidation window.

    Treatment: Continuous theta burst stimulation (cTBS)

  • Sham cTBSPlacebo, for comparison

    Participants will undergo a Functional magnetic resonance imaging (fMRI) scan while performing a fear conditioning/extinction task at CSI-EUH and then either stay at CSI-EUH or relocate to the Neural Plasticity Research Laboratory at Emory Rehabilitation Hospital. Participants will then be randomly assigned to either receive active or sham continuous theta burst stimulation (cTBS) to transiently disrupt neural activity in the targeted sensory cortex region specifically during the sensory memory consolidation window.

    Treatment: Sham continuous theta burst stimulation (cTBS)

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Forgetting Fear: Establishing a Novel Non-invasive Approach to Disrupt Fear-based Sensory Memory Consolidation in Humans
Criteria questions
Built from NCT05560113, who can take part
Record updated
29 October 2025